Screener
Praxis Precision Medicines, Inc. PRAX Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Praxis Precision Medicines, Inc.’s reported figures.
The source filing: Praxis Precision Medicines, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:32 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001689548-26-000083
FAQ
- What is Praxis Precision Medicines, Inc.'s free cash flow?
- Praxis Precision Medicines, Inc. (PRAX) reported free cash flow of -$77.79M in Q2 2026.
- How has Praxis Precision Medicines, Inc.'s free cash flow changed year-over-year?
- Praxis Precision Medicines, Inc.'s free cash flow decreased by 42.1% year-over-year, from -$54.73M to -$77.79M.
- What is the long-term trend for Praxis Precision Medicines, Inc.'s free cash flow?
- Over 4 years (2021 to 2025), Praxis Precision Medicines, Inc.'s free cash flow has grown at a 18.7% compound annual growth rate (CAGR), from -$125.6M to -$249.12M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Praxis Precision Medicines, Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude